CCCC
Price
$2.37
Change
-$0.11 (-4.44%)
Updated
Oct 17 closing price
Capitalization
220.18M
12 days until earnings call
Intraday Buy/Sell Signals
QNCX
Price
$1.86
Change
-$0.07 (-3.63%)
Updated
Oct 17 closing price
Capitalization
99.91M
26 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CCCC vs QNCX

Header iconCCCC vs QNCX Comparison
Open Charts CCCC vs QNCXBanner chart's image
C4 Therapeutics
Price$2.37
Change-$0.11 (-4.44%)
Volume$2.49M
Capitalization220.18M
Quince Therapeutics
Price$1.86
Change-$0.07 (-3.63%)
Volume$202.64K
Capitalization99.91M
CCCC vs QNCX Comparison Chart in %
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. QNCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (CCCC: $2.37 vs. QNCX: $1.86)
Brand notoriety: CCCC and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 122% vs. QNCX: 74%
Market capitalization -- CCCC: $220.18M vs. QNCX: $99.91M
CCCC [@Biotechnology] is valued at $220.18M. QNCX’s [@Biotechnology] market capitalization is $99.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, QNCX is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while QNCX’s TA Score has 6 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 6 bearish.
  • QNCX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +5.33% price change this week, while QNCX (@Biotechnology) price change was -0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

QNCX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($220M) has a higher market cap than QNCX($99.9M). QNCX YTD gains are higher at: -0.535 vs. CCCC (-34.167). QNCX has higher annual earnings (EBITDA): -41.32M vs. CCCC (-109.63M). CCCC has more cash in the bank: 215M vs. QNCX (34.7M). QNCX has less debt than CCCC: QNCX (17.5M) vs CCCC (62.9M). CCCC has higher revenues than QNCX: CCCC (34.2M) vs QNCX (0).
CCCCQNCXCCCC / QNCX
Capitalization220M99.9M220%
EBITDA-109.63M-41.32M265%
Gain YTD-34.167-0.5356,389%
P/E RatioN/AN/A-
Revenue34.2M0-
Total Cash215M34.7M620%
Total Debt62.9M17.5M359%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCQNCX
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 5 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HENKY19.050.26
+1.38%
Henkel AG & Co. KGAA
CLCFF0.04N/A
N/A
Christina Lake Cannabis Corp.
NFPDF16.71N/A
N/A
Nissin Food Products
JFHHF2.02N/A
N/A
Jupiter Fund Management Ltd.
CNRSF0.45N/A
N/A
Canadian North Resources Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-4.44%
BEAM - CCCC
43%
Loosely correlated
+0.74%
OCUL - CCCC
40%
Loosely correlated
-2.95%
AXON - CCCC
40%
Loosely correlated
+2.84%
SYRE - CCCC
40%
Loosely correlated
+1.03%
IDYA - CCCC
38%
Loosely correlated
+5.67%
More